|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.21 CAD | -4.55% |
|
+7.69% | 0.00% |
| Apr. 08 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
| Mar. 28 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Helix BioPharma Corp. filed its Annual on Oct 31, 2022 for the period ending Jul 31, 2022. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 36.68M | |
| +26.28% | 42.68B | |
| -3.99% | 42.4B | |
| +45.32% | 40.04B | |
| -6.20% | 28.31B | |
| +6.36% | 24.94B | |
| -21.47% | 18.96B | |
| +27.58% | 12.3B | |
| -2.75% | 11.95B | |
| -2.02% | 11.55B |
HELIX BIOPHARMA CORP. 
